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SUMMARY
The Enterobacteriaceae are Gram-negative bacteria and include commensal organisms as well as 
primary and opportunistic pathogens that are among the leading causes of morbidity and mortality 
worldwide. Although Enterobacteriaceae often comprise less than 1% of a healthy intestine’s 
microbiota1, some of these organisms can bloom in the inflamed gut2–5; indeed, expansion of 
enterobacteria is a hallmark of microbial imbalance known as “dysbiosis”6. Microcins are small 
secreted proteins that possess antimicrobial activity in vitro7,8, but whose role in vivo has been 
unclear. Here we demonstrate that microcins enable the probiotic bacterium Escherichia coli 
Nissle 1917 (EcN) to limit expansion of competing Enterobacteriaceae (including pathogens and 
pathobionts) during intestinal inflammation. Microcin-producing EcN limited growth of 
competitors in the inflamed intestine, including commensal E. coli, adherent-invasive E. coli, and 
the related pathogen Salmonella enterica. Moreover, only therapeutic administration of the wild-
type, microcin-producing EcN to mice previously infected with S. enterica substantially reduced 
intestinal colonization of the pathogen. Our work provides the first evidence that microcins 
mediate inter and intra-species competition among the Enterobacteriaceae in the inflamed gut. 
Moreover, we show that microcins can be narrow-spectrum therapeutics to inhibit enteric 
pathogens and reduce enterobacterial blooms.
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TEXT
Broad-spectrum antibiotics are largely unsuccessful in treating enterobacterial gut infections. 
Efforts to identify novel therapeutics can be aided by identifying mechanisms beneficial 
microbes employ to mediate colonization resistance to pathogens9,10. Reports of microcin-
producing Enterobacteriaceae in human stool led to hypotheses that microcins contribute gut 
microbial ecology11. Here we sought to identify an in vivo role for microcins by studying 
Escherichia coli Nissle 1917 (EcN)12,13 and its interplay with related competitors in the gut. 
Similar to bacteriocins of Gram-positive bacteria, microcins can exhibit potent antibacterial 
activity in vitro14–16. In contrast to bacteriocins15, a compelling in vivo role for microcins 
has not previously been demonstrated17.
EcN’s microcin gene cluster resides on Genomic Island I (Extended Data Fig. 1a and 
Supplementary Table 1) and encodes for microcin M (mcmA), microcin H47 (mchB), and 
their cognate immunity genes (mcmI and mchI, respectively). To understand whether EcN’s 
microcins promote colonization of the healthy intestine, we intragastrically inoculated 
specific pathogen-free (SPF) mice with an equal mixture of a mouse commensal E. coli 
(cEc) strain18 and either wild-type EcN or a mutant unable to secrete both microcins (EcN 
mchDEF)14. Although all strains poorly and transiently colonized the healthy intestine 
(enterobacteria typically colonize at low levels in this setting), cEc colonization was not 
significantly impacted by either wild-type EcN or EcN mchDEF, and cEc outcompeted both 
strains to a similar extent (Extended Data Fig. 1b–g).
To determine whether low colonization masked a microcin phenotype, we performed similar 
studies in germ-free mice and in streptomycin-treated SPF mice. We administered cEc alone 
or in competition with wild-type EcN, EcN mchDEF, or an EcN mcmA mchB mutant that 
lacks both microcin genes. All strains colonized the gut to high levels in these models, 
however cEc colonization was again unaffected by competition with EcN wild-type or 
microcin mutants (Fig. 1a,b). Moreover, there were no significant differences in colonization 
among EcN strains (Fig. 1c,d), and cEc outcompeted EcN wild-type and microcin mutants 
to a similar extent (Fig. 1e,f). Together, these results indicate EcN’s microcins do not 
provide a competitive advantage under homeostatic conditions (Fig. 1g).
Prior work showed antibacterial activity for EcN’s microcins in iron-limited media14. 
Moreover, a subset of microcins are post-translationally modified at the C-terminus with a 
siderophore moiety19–21, and EcN’s microcins are thought to be modified by a similar 
mechanism14,21. In response to iron starvation, commensals and pathogens synthesize and 
secrete siderophores to acquire this essential metal nutrient22. Bacterial uptake of iron-bound 
siderophores occurs via specific membrane receptors14. Microcins conjugated to 
siderophores are also synthesized during iron starvation, and can target non-immune bacteria 
in vitro through cognate siderophore receptors14,16, a mechanism described as a ‘Trojan 
horse’ mode of action7. Incorporating these observations, we hypothesized that microcins 
contribute to competition among enterobacteria in the inflamed gut, where iron is limited23.
We confirmed EcN’s microcins (mcmA, mchB) are expressed in iron-limited media, and not 
in iron-rich media (Fig. 1h). To identify a role for microcins during intestinal inflammation, 
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we utilized the dextran sulfate sodium (DSS)-treated mouse model of colitis (Fig. 2a). First, 
we intragastrically inoculated DSS-treated SPF mice with an equal mixture of cEc and wild-
type EcN, EcN mchDEF, or EcN mcmA mchB. Although cEc initially outcompeted (~10-
fold) wild-type EcN, both strains colonized the intestine equally well by day 5 post-
inoculation. In contrast, cEc greatly outcompeted (up to 10,000-fold) the microcin mutants 
(Fig. 2b and Extended Data Fig. 2a). While intestinal colonization of cEc was similar when 
alone or in competition with wild-type EcN or a microcin mutant at day 1–3 post-
inoculation, only wild-type EcN significantly reduced cEc colonization at later timepoints 
(Fig. 2c and Extended Data Fig. 2b,h). Consistent with this, in vitro killing of cEc was only 
observed in iron-limited media when competing with wild-type EcN, not the microcin 
mutants (Extended Data Fig. 3a–d). As the EcN microcin mutants still express cognate 
microcin immunity proteins, their competitive growth in vitro was not impaired (Extended 
Data Fig. 3c–g) until the immunity genes were deleted (Extended Data Fig. 3h,i). 
Nevertheless, gut colonization of microcin mutants was similarly reduced in competition 
with cEc (Fig. 2d and Extended Data Fig. 2c,i), whereas trans-complementation of EcN 
mchDEF restored colonization (Fig. 2b–d). As cEc was isolated from the murine gut, cEc is 
plausibly better adapted to growth in this environment than is EcN, a human isolate. 
Microcins thus give EcN a means by which to compete.
In contrast to competition with cEc, colonization of microcin mutants was not impaired in 
DSS-treated mice when strains were administered alone or in competition with wild-type 
EcN (Fig. 3a–c and Extended Data Fig. 4a–d). Microcin mutants exhibited a 5–10-fold 
advantage over wild-type EcN at day 5 post-inoculation (Fig. 3c), which may result from the 
mutants still being immune to microcins and not expending energy on microcin production; 
relatedly, wild-type EcN rescued colonization of microcin mutants when co-administered 
with cEc in DSS-treated mice (Extended Data Fig. 4e–h). Microcin mutants are thus not 
intrinsically attenuated. Moreover, our findings indicate that microcins enable EcN to limit 
expansion of a related commensal in the inflamed gut (Extended Data Fig. 2d–g), where 
Enterobacteriaceae thrive but also compete with each other for space and limited nutrients 
(niche competition).
We next tested whether iron supplementation during colitis inhibited microcin activity. Mice 
fed an iron-rich diet three weeks prior to and during DSS treatment developed colitis, yet 
wild-type EcN did not reduce colonization of cEc. Instead, both EcN wild-type and EcN 
mchDEF were outcompeted by cEc and exhibited similar levels of gut colonization 
(Extended Data Fig. 5a–e). Thus, if iron is supplemented, microcins do not limit expansion 
of a competitor in the inflamed gut, likely because microcins, siderophores and siderophore 
receptors (i.e., microcin receptors) are only expressed during iron starvation14,23. These 
observations also suggest that, in contrast to broad-spectrum antibiotics, siderophore-linked 
microcins would have a limited effect on the gut microbiota as they target strains that 
acquire those siderophores.
As microcins mediated competition between EcN and cEc in the DSS-colitis model, we 
analyzed the intestinal microbiota in this setting. DSS treatment reduced the gut 
microbiota’s diversity (Extended Data Fig. 5f), and subsequent administration of wild-type 
EcN or EcN mchDEF yielded similar shifts in microbial communities (Extended Data Fig. 
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5f,g and Supplementary Table 2). These results indicate that, at least in our DSS-treated 
mice, EcN’s microcins did not substantially change the gut microbiota, which is consistent 
with their predicted narrow spectrum.
In addition to some commensal Enterobacteriaceae, some enterobacterial pathogens thrive in 
the inflamed gut3. We therefore investigated microcins’ activity against the diarrheal 
pathogen Salmonella enterica serovar Typhimurium (STm). We first established that wild-
type EcN, but not EcN mchDEF or EcN mcmA mchB, only killed STm in iron-limited 
media (Extended Data Fig. 6a–e). When streptomycin-treated mice (Salmonella colitis 
model) were co-administered STm and either wild-type EcN or EcN mchDEF, only wild-
type EcN outcompeted STm beyond day 4 post-infection (Fig. 3d,e). Although all strains 
initially colonized the gut to similar levels, reduction of STm colonization was significantly 
enhanced by microcin-producing EcN (Fig. 3f). By day 7, wild-type EcN and EcN mchDEF 
had similarly reduced STm colonization, likely because EcN has other mechanisms to 
outcompete STm, including a greater ability to acquire iron23. Nevertheless, in agreement 
with our cEc results (Fig. 2a–d), gut colonization of EcN mchDEF was drastically reduced 
in competition with STm 7 days after co-administration (Fig. 3g). Moreover, wild-type 
EcN’s competitive advantage over STm was again only observed during intestinal 
inflammation (Extended Data Fig. 7a,b). Relatedly, wild-type EcN and EcN mchDEF 
showed similar levels of intestinal colonization and no competitive advantages when 
competed with STm invA spiB, a mutant in both type-three secretion systems that is unable 
to trigger gut inflammation as it cannot invade the intestinal epithelium or replicate 
intracellularly (Extended Data Fig. 7c–e).
Consistent with our STm and cEc results, microcins impaired growth of adherent invasive E. 
coli (AIEC), a pathobiont frequently isolated from Crohn’s disease patients. Wild-type EcN, 
but not EcN mchDEF, was able to reduce AIEC growth in vitro (Extended Data Fig. 6f–i) 
and in the DSS-colitis model (Extended Data Fig. 8). Although AIEC and wild-type EcN 
colonized the inflamed gut to similar levels, AIEC significantly outcompeted EcN mchDEF 
in this environment (Extended Data Fig. 8). Collectively, our data indicate that EcN 
produces microcins to limit growth of competing enterics in the inflamed gut.
We next investigated whether microcins could therapeutically treat an active enterobacterial 
infection, administering EcN wild-type or EcN mchDEF to mice previously infected with 
STm (Fig. 4a). Mice receiving wild-type EcN at days 2 and 5 post-STm infection showed 
substantially reduced STm gut colonization (average 1,300-fold; up to 100,000-fold), 
inflammation and weight loss (Fig. 4b–d and Extended Data Fig. 9). This phenotype largely 
depended on microcins, as EcN mchDEF only minimally reduced STm intestinal burden 
(~17-fold), and did not reduce inflammation or weight loss (Fig. 4b–d and Extended Data 
Fig. 9). To better understand the therapeutic phenotype, we assayed each microcin’s 
antibacterial activity.
While microcins M and H47 showed antibacterial activity against AIEC, only M was 
effective against STm and cEc (Extended Data Fig. 10a–c); the H47-resistance mechanism is 
unknown as neither strain carries mchI. Accordingly, STm engineered to express mchI (STm 
pMchI) was not rescued in competition with wild-type EcN, whereas STm pMcmI was 
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rescued (Extended Data Fig. 10d,e). Strikingly, therapeutic administration of EcN only 
minimally impaired colonization of the microcin-resistant STm pMcmI (Fig. 4b and 
Extended Data Fig. 9). Furthermore, inflammation, weight loss and STm colonization were 
comparable when either EcN mchDEF or STm pMcmI were used in the therapeutic 
experiment (Fig. 4b–d and Extended Data Fig. 9).
Altogether, we provide the first in vivo evidence that microcins mediate competition among 
Enterobacteriaceae in the inflamed gut. We show that the probiotic bacterium EcN employs 
microcins to compete with related species, colonize the inflamed gut, and therapeutically 
displace an enteric pathogen from its niche. EcN’s microcins target microbes expressing 
particular siderophore receptors, and do not severely impact the microbiota. Although 
siderophore receptor mutants are resistant (14 and Extended Data Fig. 10f–h), they are 
attenuated in the inflamed intestine24 and thus unlikely to be selected for. As microcins were 
particularly effective during therapeutic EcN administration to pathogen-infected, inflamed 
mice, these or similar compounds (e.g., siderophore-conjugated antibiotics25) could 
conceivably be utilized as a targeted strategy to treat enterobacterial colitis.
METHODS
Bacterial Strains, culture conditions and chemicals
Strains of the probiotic Escherichia coli Nissle 1917 (EcN; Mutaflor, DSM 6601), the mouse 
commensal Escherichia coli (cEc), the adherent invasive E. coli (AIEC), and the pathogen 
Salmonella enterica serovar Typhimurium (STm) utilized in this study are listed in 
Supplementary Table 3. All plasmids used in this study are listed in Supplementary Table 4. 
EcN was kindly provided by Ardeypharm Gmb, Herdecke, Germany. The commensal E. coli 
strain was isolated from mice in our vivarium and does not appear to encode for known 
antibacterial exoproducts. The AIEC strain is a human isolate from a patient with Crohn’s 
disease (isolate NRG857c O83:H1)26 and was kindly provided by Dr. Alfredo Torres. IR715 
is a fully virulent, nalidixic acid-resistant derivative of STm wild-type isolate ATCC 14028, 
and does not encode for known antibacterial exoproducts. All strains were routinely grown 
aerobically in Luria-Bertani (LB) broth (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl) 
or on LB agar plates at 37 °C. When indicated, antibiotics were added to the media at the 
following concentrations: 0.03 mg/mL chloramphenicol (Cm); 0.1 mg/mL carbenicillin 
(Carb); 0.05 mg/mL kanamycin (Kan); 0.01 mg/mL tetracycline (Tet). For animal infections 
or bacterial administration, all strains were grown in LB media aerobically at 37 °C 
overnight. For in vitro growth assays, strains were grown in iron-limiting conditions 
(Nutrient Broth supplemented with 0.2 mM 2,2′-dipyridyl dissolved in ethanol; Sigma) 
aerobically at 37 °C overnight. Restrictions enzymes and Phusion High Fidelity DNA 
Polymerase were purchased from New England Biolabs. Oligonucleotides were synthesized 
by Fisher Scientific and are listed in Supplementary Tables 5 and 6.
Generation of bacterial mutants
Mutants in EcN and STm were constructed using the lambda red recombinase system27. 
Briefly, primers (Supplementary Table 5) homologous to sequences flanking the 5′ and 3′ 
ends of the target regions were designed (H1 and H2 primers, respectively; Supplementary 
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Table 5) and were used to replace the selected genes with a chloramphenicol (derived from 
pKD3), kanamycin (derived from pKD4), or tetracycline resistance cassettes 
(Supplementary Table 4). Strain names for the mutants are listed in Supplementary Table 3. 
To confirm integration of the resistance cassette and deletion of the target, mutant strains and 
wild-type controls were each assayed utilizing three PCR amplifications (5′ end, 3′ end, 
deleted target) to validate mutations. Primers (Supplementary Table 5) that flank the target 
sequence were used in conjunction with a common test primer (C1, C2, K1, K2 or primers 
for the tetRA cassette) to test for both new junction fragments.
Complementation studies
The mchDEF region was amplified from EcN genomic DNA using primers listed in 
Supplementary Table 5. A region of 4148 bp was amplified to ensure all regulatory elements 
were included. The PCR fragment was cloned into plasmid pCR-XL-TOPO using 
Invitrogen’s Zero Blunt TOPO PCR Cloning Kit’s provided protocol, subcloned into the 
multiple cloning site of low copy plasmid pWSK29, and confirmed by Sanger sequencing 
(Eton Bioscience). The mchDEF mcmI and mchDEF mchI constructs were amplified from 
EcN genomic DNA using primers listed in Supplementary Table 5. PCR fragments of 4321 
bp (mchDEFmcmI), 4000 bp (mchDEF) and 400 bp (mchI) were directly assembled with 
plasmid pWKS30 using the Gibson assembly method.
In vitro growth assays
The role of EcN’s microcins against cEc, AIEC and STm was tested by in vitro competitive 
growth assay in iron-rich and iron-limiting conditions. Strains were grown in Nutrient Broth 
supplemented with 0.2mM 2,2′-dipyridyl (Sigma) aerobically at 37 °C overnight. 
Approximately 5×103 CFU/mL from an overnight culture were inoculated into 0.1 mL of 
tissue culture medium (DMEM/F12 with 10% fetal bovine serum (FBS); Invitrogen), as 
previously described23,24. When indicated, media was prepared with 1 μM ferric iron citrate 
(Sigma). Wild-type EcN or EcN mutants were inoculated in competition with wild-type 
STm, STm mutants, cEc, or AIEC. CFUs of each strain were enumerated by plating serial 
dilutions at 0, 5, 8, 11 and (for some assays) 16 h post-inoculation.
Mice
The Institutional Animal Care and Use Committee at the University of California, Irvine 
approved all mouse experiments. Eight to ten-week-old male and female C57BL/6 
NRAMP1+ mice were bred and housed in our vivarium. For some experiments, mice were 
purchased from Jackson laboratory and upon arrival allowed to acclimate to the new 
environment for at least one week prior to the start of an experiment. All mice were housed 
under specific pathogen-free conditions. Mice were fed an irradiated 2920X Teklad diet 
(Envigo). For one experimental procedure mice were fed an irradiated iron rich diet (1% 
Diet FeSO4 2020, Teklad TD 160234; Envigo). Culturing feces on MacConkey agar 
indicated that culturable enterobacteria were absent from our mice. Five to ten mice were 
used per experimental group, as indicated by the number of symbols in each figure panel. 
Group sizes were based on previous studies that detected a 10-fold difference with statistical 
significance. For one experiment, 10 week-old Swiss Webster germ-free mice were used. 
Swiss Webster germ-free mice were maintained in sterile isolators and were fed a double-
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irradiated diet (Purina 5066, Charles River Rodent 18% Vac Pac). 3 mice per experimental 
group were used for this experimental procedure (see figure panels). Mice were randomly 
grouped in cages of a maximum five animals per cage. Similar numbers of male and female 
mice were used in each experimental group. No blinding was performed, with the exception 
of histopathology.
Dextran sulfate sodium-induced colitis mouse model
Drinking water was replaced with either filter-sterilized water (mock-treatment) or with a 
filter-sterilized solution of 4% (w/v) dextran sulfate sodium (DSS; relative molecular mass 
36,000–50,000; MP Biomedicals, Santa Ana) in water as indicated. For DSS- treated mice, 3 
days prior to the end of the experiment, drinking water was switched for 24h to filter-
sterilized water. Drinking water was then replaced with either filter-sterilized water (mock-
treatment) or with a filter-sterilized solution of 2% (w/v) DSS. 4 days after the start of DSS 
treatment, animals were orally inoculated with a 1:1 ratio of 5×108 CFU of wild-type EcN 
and mutants in competition with cEc or AIEC strains (resuspended in 0.1 mL LB broth). 
Fecal material was collected each day after bacterial administration, resuspended in sterile 
PBS and the bacterial load was determined by plating serial 10-fold dilutions on selective 
agar plates. Animals were euthanized 5 days after inoculation. Cecal tissue was collected 
then flash frozen in liquid nitrogen and stored at −80 °C for later isolation of mRNA and 
protein. The cecal tip was fixed in 10% formalin for histopathology. Fecal material and cecal 
content were harvested in sterile PBS and the bacterial load for the E. coli strains was 
determined by plating serial 10-fold dilutions on selective agar plates. At some timepoints, a 
mouse did not produce fecal material, hence an n is displayed for a given timepoint that is 
less than the experiment’s indicated n for that group. To differentiate EcN from other E. coli 
strains in biological samples, the strains were differentially marked with the low-copy 
number pACYomega (Cm) or pHP45omega (Carb) (Supplementary Table 4), and markers 
were swapped in some experiments. Plasmids were stably maintained throughout the 
infection and similar colonies were counted in other differential media such as MacConkey 
agar (not shown). When noted, the ratio of two strains in the feces and cecal content was 
calculated by dividing the output ratio (EcN CFU/cEc or AIEC CFU) by the input ratio 
(EcN CFU/cEc or AIEC CFU). The competitive index was calculated for isogenic strains by 
dividing the output ration (EcN wild-type CFU/mutant CFU) by the input ration (EcN wild-
type CFU/mutant CFU).
Salmonella Typhimurium-induced colitis
C57BL/6 NRAMP1+ mice were treated with streptomycin (100 μL of a 200 mg/mL solution 
in sterile water) one day prior to infection. The following day, mice were orally inoculated 
with 1×109 CFU of STm (resuspended in 0.1 mL LB broth) or with a 1:1 ratio of 5×108 
CFU each of STm and wild-type EcN, or EcN mchDEF strain for competitive colonization 
experiments. For therapeutic administration of EcN after STm infection, C57BL/6 
NRAMP1+ mice were treated with streptomycin (100 μL of a 200 mg/mL solution in sterile 
water) one day prior to STm infection. The following day, mice were orally inoculated with 
1×109 CFU of STm. At days 2 and 5 after STm infection, mice were either mock-treated or 
treated with 1×109 CFU of wild-type EcN or EcN mchDEF. Fecal material was collected 
each day after bacterial administration, resuspended in sterile PBS, then bacterial load for 
Sassone-Corsi et al. Page 7
Nature. Author manuscript; available in PMC 2017 April 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
STm and EcN strains was determined by plating serial 10-fold dilutions on selective agar 
plates. At some timepoints, a mouse did not produce fecal material, hence an n is displayed 
for a given timepoint that is less than the experiment’s indicated n for that group. At day 7 
post-infection, mice were euthanized and a portion of the cecum was flash frozen in liquid 
nitrogen then stored at −80 °C for later isolation of mRNA and protein. The cecal tip was 
fixed in 10% formalin for histopathology. Bacteria were enumerated in the fecal content by 
plating serial 10-fold dilutions on LB agar plates containing appropriate antibiotics. To 
selectively identify STm from EcN strain in the fecal content, strains were differentially 
marked with the low-copy number pACYomega (Cm) or pHP45omega (Carb) plasmids. 
Plasmids were stably maintained throughout the infection and similar colonies were counted 
in other differential media such as MacConkey agar (not shown). When noted, ratio of two 
strains was calculated by dividing the output ratio (EcN CFU/STm CFU) by the input ratio 
(EcN CFU/STm CFU).
Extraction of bacterial DNA from fecal samples
Fecal samples were collected prior to DSS treatment (day -4), at day 4 post-DSS treatment 
(day 0; before inoculation of bacteria) and at day 5 post-administration of commensal E. coli 
in competition with wild-type EcN or EcN mchDEF. Feces were snap frozen in liquid 
nitrogen, then DNA was later extracted using the QIAamp DNA Stool Kit (Qiagen) 
according to the manufacturer’s instructions with modifications as previously described18. 
Because DSS interferes with PCR, we used the following procedure (developed by Dr. 
Wenhan Zhu and Dr. Sebastian Winter, UT Southwestern) to eliminate DSS from samples. 
Samples were eluted in 200 μl of ultrapure water and combined with 80 mg of KCl followed 
by vortexing for 2 min. The mixture was then incubated on ice for 30 min and centrifuged at 
16,800 × g at 4 °C for 30 min. The supernatant was then transferred to a new tube and 1/10 
volume of 3 M NaAc (pH 5.2) was added. 2.5 mL of pure ethanol was then added to the 
mixture, vortexed and centrifuged at 16,800 × g at 4 °C for 30 min. The supernatant was 
removed and 1 mL of 70% Ethanol was added to the pellet, vortexed and centrifuged at 
16,800 × g for 5 min at RT. This wash step was repeated 3–4 times. The pellet was then air 
dried at 55 °C and resuspended in 30 μl of ultra-pure water.
Analysis of microbiota
DNA extracted from fecal samples was amplified by a two-step PCR enrichment of 16S 
rDNA (V4 region) with primers 515F and 806R modified by addition of barcodes for 
multiplexing, then sequenced on an Illumina MiSeq system (UC Davis HMSB Facility). 
Sequences were processed and analyzed by employing the QIIME pipeline v1.9.128 with 
default settings, except as noted. In brief: paired-end sequences were joined, quality filtered, 
reverse complemented, and chimera filtered (usearch61 option; RDP gold database); 
operational taxonomic units (OTUs) were picked (usearch61 option; 
enable_rev_strand_match True) at 97% similarity; taxonomy was assigned (confidence 0.8) 
with the RDP classifier. Greengenes database v13_8 was utilized in the open-reference OTU 
picking workflow.
Sassone-Corsi et al. Page 8
Nature. Author manuscript; available in PMC 2017 April 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Bacterial RNA extraction
A bacterial RNA mini kit (Bio-Rad Aurum Total) was used to extract RNA from bacterial 
cultures. EcN strains were grown in Nutrient Broth supplemented with 0.2 mM 2,2′-
dipyridyl aerobically at 37 °C overnight. Approximately 104 CFU/mL from an overnight 
culture were inoculated into 5 mL of tissue culture medium (DMEM/F12 plus 10% fetal 
bovine serum, Invitrogen), as previously described23,24. When indicated, iron citrate was 
added to the media at a final concentration of 1μM. At 7 h post-inoculation, 2×109 CFU 
were used to extract RNA. An additional DNAse treatment (Ambion) was done prior to the 
generation of cDNA with reverse transcription reagents (Roche).
Quantitative Real-Time PCR
For analysis of gene expression by quantitative real-time PCR, total RNA was extracted 
from cecal tissue with TRI Reagent (Molecular Research Center; Cincinnati, OH). RNA 
from DSS-treated mice was further purified using the Dynabeads mRNA DIRECT 
Purification Kit (Life Technologies) according to manufacturer recommendations. Reverse 
transcription reagents (Roche) were employed to generate cDNA from all RNA samples. 
Real-time PCR was performed using SYBR Green (Roche, Indianapolis, IN) and the Roche 
Lightcycler 480 Instrument II system (Roche, Indianapolis, IN). Data were analyzed using 
the comparative delta-delta-Ct method. Target gene transcription of each tissue sample was 
normalized to the respective levels of Actb mRNA (β-actin). For qPCR analysis of bacterial 
transcripts, transcription of mcmA and mchB was normalized to bacterial gapA mRNA 
levels. Data represents at least three independent experiments. DNA contamination was less 
than 1% for all bacterial amplicons, as determined by separate mock reactions lacking 
reverse transcriptase. All primers used are listed in Supplementary Table 6.
Histopathology analysis
Tissue samples were fixed in 10% formalin, processed according to standard procedures for 
paraffin embedding, sectioned at 5 mm, and stained with hematoxylin and eosin. The 
pathology score of cecal samples was determined by blinded examination of cecal sections 
from a board-certified pathologist using previously published methods18. Each section was 
evaluated for the presence of neutrophils, mononuclear infiltrate, submucosal edema, surface 
erosions, inflammatory exudates, and cryptitis. Inflammatory changes were scored from 0 to 
4 according to the following scale: 0 = none; 1 = low; 2 = moderate; 3 = high; 4 = extreme. 
The inflammation score was calculated by adding up all scores obtained for each parameter 
and interpreted as follows 0–2 = within normal limit; 3–5 = mild; 6–8 = moderate; 8+ = 
severe.
Statistical analysis of data
Prism 6 and 7 software (Graphpad) was used for statistical analysis. Bacterial growth curves 
were analyzed by unpaired Student’s t test. To compare bacterial CFUs in feces and cecal 
content, mRNA expression, and eubacterial taxa present at greater than 0.5% relative 
abundance in at least one sample, we applied a non-parametric Mann-Whitney-Wilcoxon 
test. We chose this test because it can be applied to data with normal or unknown 
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distribution. P-values for all statistical comparisons presented in the main and extended data 
figures are available in Supplementary Table 7.
Data availability
The data that support the findings of this study are available from the corresponding author 
upon request. Fecal microbiota 16S rDNA sequencing data were deposited in the European 
Nucleotide Archive under accession PRJEB15700.
Extended Data
Extended Data Figure 1. E. coli Nissle wild-type and microcin mutant (mchDEF) gut 
colonization in competition with commensal E. coli in the absence of intestinal inflammation
a, Illustration of the microcin gene cluster in EcN. b–g, Intragastric inoculation of SPF mice 
with cEc alone or in competition with wild-type EcN or EcN mchDEF at a 1:1 ratio. b, Ratio 
(EcN over cEc) in fecal content at days 1–5 post-inoculation (n = 5/group). c,d, CFU/mg of 
(c) cEc or (d) wild-type EcN or EcN mchDEF in fecal content at days 1–5 post-inoculation, 
when cEc was administered alone or in competition as indicated. e,f, Cecal (e) 
histopathology scores or (f) gene expression (data are expressed as fold change over mock-
treated mice) at day 5 post-inoculation for panels b–d (n = 5/group). g, H&E-stained 
sections from representative animals at day 5 post-inoculation; scale bar = 100 μm. b,f, Bars 
= geometric mean ± s.e.m. c–e, Individual symbol = mouse. c,d, Bars = geometric mean. e, 
Bars = mean. n.s., not significant.
Sassone-Corsi et al. Page 10
Nature. Author manuscript; available in PMC 2017 April 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Extended Data Figure 2. Colonization and histopathology of E. coli Nissle wild-type and 
microcin mutants (mchDEF and mcmA mchB) in competition with commensal E. coli, in mice 
with DSS-mediated colitis
a–i, Experimental design as in Fig. 2a with SPF mice. a, Ratio (EcN over cEc) in cecal 
content at day 5 post-intragastric inoculation (n = 6/group). b,c, CFU/mg of (b) cEc or (c) 
wild-type EcN or EcN mchDEF in fecal content at day 5 post-inoculation when in 
competition as indicated (n = 6/group). d,e, Cecal (d) gene expression (n = 5/group) data are 
presented as fold change over mock-treated mice) or (e) histopathology scores at day 5 post-
inoculation from mice shown in panels b,c and Fig. 2b–d (DSS only, n = 3; all others, n = 5); 
scale bar = 100 μm. f, Detailed histopathology scoring of panel e mice. g, H&E-stained 
sections from representative animals at day 5 post-inoculation. h,i, CFU/mg of (h) cEc or (i) 
Sassone-Corsi et al. Page 11
Nature. Author manuscript; available in PMC 2017 April 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
wild-type EcN or EcN mcmA mchB in sample content at days 1–5 post-intragastric 
inoculation when cEc was administered alone or in competition as indicated (n = 5/group). 
a,d, Bars = geometric mean ± s.e.m. b,c,e,h,i, Individual symbol = mouse. b,c,h,i, Bars = 
geometric mean. e, Bars = mean. *P<0.05, **P<0.01; n.s., not significant.
Extended Data Figure 3. In vitro growth curves of E. coli Nissle and microcin mutants when 
grown alone or in competition with EcN mutants or commensal E. coli
a–i, Strains were grown overnight in Nutrient Broth + 0.2 mM 2,2’-dipyridyl. Growth assays 
were performed in iron-limiting conditions (DMEM/F12 + 10% FBS) or in media 
supplemented with 1 μM iron citrate. Timepoints at 0, 5, 8 and 11 hours post-inoculation 
were collected. a,b, cEc CFU/mL when grown alone or in competition with wild-type or 
mutant EcN in (a) iron-limiting conditions or in (b) media supplemented with 1 μM iron 
citrate. c,d, CFU/mL of wild-type or mutant EcN when grown alone or in competition with 
cEc in (c) iron-limiting conditions or in (d) media supplemented with 1 μM iron citrate. e–g, 
Under iron-limiting conditions, CFU/mL of (e) wild-type or mutant EcN when grown alone, 
or of (f) wild-type EcN or (g) EcN mchDEF or EcN mcmA mchB when grown 
competitively as indicated. h,i, CFU/mL of the indicated EcN mutants (immunity gene(s) 
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and/or mchDEF) grown in competition with wild-type EcN in (h) iron-limiting conditions or 
in (i) media supplemented with 1 μM iron citrate. a–i, Symbols = geometric mean (three 
independent experiments) ± s.e.m. **P<0.01, ***P<0.001, ****P<0.0001.
Extended Data Figure 4. Gut colonization of E. coli Nissle wild-type and microcin mutants in the 
DSS-colitis model
a, Experimental design for b-d with SPF mice. b, CFU/mg of wild-type EcN or EcN 
mchDEF in fecal content at days 1–5 post-intragastric inoculation (n = 5/group). c,d, Cecal 
(c) gene expression (n = 5/group; data are expressed as fold change over mock-treated mice) 
or (d) H&E-stained sections (representative) from panel b mice at day 5 post-inoculation; 
scale bar = 100 μm. e, Triple co-administration design for f–h with SPF mice. f,g, CFU/mg 
of (f) cEc or (g) indicated EcN strain in fecal content at days 1–5 post-intragastric 
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inoculation with cEc, wild-type EcN and the indicated EcN mutant (n = 5/group). h, 
Competitive index (CI; EcN wild-type over mutant) for EcN data presented in panel g (n = 
5/group). b,f,g, Individual symbol = mouse; bars = geometric mean. c,h, bars = geometric 
mean ± s.e.m. *P<0.05, **P<0.01; n.s., not significant.
Extended Data Figure 5. Impact of microcins on the microbiota and impact of a high iron diet on 
microcin-mediated competition
a, High-iron diet design for b–e with SPF mice (n = 5/group) b, Ratio (EcN over cEc) in 
fecal content at days 1–5 post-intragastric inoculation. c, Cecal gene expression at day 5 
post-inoculation (n = 3–4/group). d,e, CFU/mg of (d) cEc or (e) wild-type EcN or EcN 
mchDEF in indicated samples at days 1–5 post-inoculation when cEc was administered 
alone or in competition as indicated (n = 5/group). f,g, See Fig. 2a for experimental design 
with SPF mice. 16S ribosomal rRNA gene sequence analysis (V4 region) of fecal DNA 
obtained from mice pre-DSS administration (Day -4), post-DSS (Day 0), and day 5 post-
intragastric inoculation of cEc with either wild-type EcN or EcN mchDEF at a 1:1 ratio. f, 
Eubacterial alpha diversity (inverse Simpson index); Shannon index yielded similar results. 
g, Principal coordinates (PCo) analysis plot (PCo1 vs. PCo2) of eubacterial beta diversity 
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(weighted UniFrac); symbols as in panel f. b,c, Bars = geometric mean ± s.e.m. d,e,f,g, 
Individual symbol = mouse. d,e, bars = geometric mean. f, bars = mean ± s.d. n.s., not 
significant. Black symbols = comparisons within same day; red symbols = comparisons 
between days.
Extended Data Figure 6. In vitro activity of E. coli Nissle microcins against S. Typhimurium and 
AIEC
a–i, Strains were grown overnight in Nutrient Broth + 0.2 mM 2,2′-dipyridyl. Growth assays 
were performed in iron-limiting conditions (DMEM/F12 + 10% FBS) or in media 
supplemented with 1 μM iron citrate. Timepoints at 0, 5, 8 and 11 hours post-inoculation 
were collected. a,b, STm CFU/mL when grown alone or in competition with wild-type or 
mutant EcN in (a) iron-limiting conditions or in (b) media supplemented with 1 μM iron 
citrate. c, STm CFU/mL in iron-limiting conditions when in competition with wild-type EcN 
or an EcN mchDEF strain harboring either pWSK29::mchDEF or empty vector control. d,e, 
CFU/mL of wild-type or mutant EcN when grown alone or in competition with STm in (d) 
iron-limiting conditions or in (e) media supplemented with 1 μM iron citrate. f,g, AIEC 
CFU/mL when grown alone or in competition with wild-type or mutant EcN in (f) iron-
limiting conditions or in (g) media supplemented with 1 μM iron citrate. h,i, CFU/mL of 
wild-type or mutant EcN when grown alone or in competition with AIEC in (h) iron-limiting 
conditions or in (i) media supplemented with 1 μM iron citrate. a–i, Symbols = geometric 
mean (three independent experiments) ± s.e.m. *P<0.05, **P<0.01, ***P<0.001, 
****P<0.0001.
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Extended Data Figure 7. Co-administration of S. Typhimurium with E. coli Nissle wild-type or 
EcN mchDEF
a–e, See Fig. 3d for co-administration design with SPF mice. a,b, Intragastric inoculation 
with wild-type STm. Cecal (a) gene expression (STm only, n = 7; all others, n = 9); data are 
expressed as fold change over mock-treated mice or (b) histopathology (STm only and STm 
+ wild-type EcN, n = 5; STm + EcN mchDEF, n = 4) from mice shown in Fig. 3f,g at Day 7 
post-infection. c–e, Intragastric inoculation with STm invA spiB. c,d, CFU/mg of (c) STm 
invA spiB (n = 4) or (d) wild-type EcN or EcN mchDEF in fecal content at designated 
timepoints post-infection when STm invA spiB was administered alone or in competition as 
indicated (n = 5/group). e, Ratio of wild-type EcN or EcN mchDEF over STm invA spiB in 
fecal content at designated timepoints post-infection (n = 5/group). a,e, Bars = geometric 
mean ± s.e.m. b–d, Individual symbol = mouse. b, Bars = mean. c,d, Bars = geometric 
mean. n.s., not significant.
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Extended Data Figure 8. Gut colonization of AIEC in DSS-treated mice when competing with E. 
coli Nissle wild-type or EcN mchDEF
a, Experimental design for b–f with SPF mice. b, Ratio of wild-type EcN or EcN mchDEF 
over AIEC in fecal content at days 1–5 post-intragastric inoculation (n = 9/group). Bars = 
geometric mean ± s.e.m. c,d, CFU/mg of (c) AIEC or (d) wild-type EcN or EcN mchDEF in 
fecal content at days 1–5 post-inoculation when AIEC was administered alone or in 
competition as indicated (n = 9/group). e, Cecal histopathology scores at day 5 post-
inoculation for panels c,d (n = 5/group). f, Detailed histopathology scoring of panel e mice. 
b, Bars = geometric mean ± s.e.m. c–e, Individual symbol = mouse. c,d, Bars = geometric 
mean. e, Bars = mean. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001; n.s., not significant.
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Extended Data Figure 9. Therapeutic administration of E. coli Nissle wild-type, EcN mchDEF or 
mock during S. Typhimurium infection
a–j, See Fig. 4a for therapeutic design with SPF mice. a–f, Intragastric inoculation with 
wild-type STm. a, Ratio of wild-type EcN or EcN mchDEF over STm in fecal content on 
days 4–7 post-infection with STm (n = 8/group). b,c,e, STm CFU/mg at designated 
timepoints post-infection in fecal content of mice therapeutically treated with (b) mock (n = 
7), (c) wild-type EcN (n = 8) or (e) EcN mchDEF (n = 8). d,f, CFU/mg of (d) wild-type EcN 
or (f) EcN mchDEF in fecal content at designated timepoints post-STm infection. g,h, 
Intragastric inoculation with STm pMcmI (n = 10/group). CFU/mg of (g) STm pMcmI or 
(h) wild-type EcN in fecal content at designated timepoints post-STm pMcmI infection. 
Grey box represents average STm CFU/mg in mock-treated mice (panel b). i, Cecal 
histopathology scores for panels b–f (STm alone, n = 6; all others, n = 7). j, Detailed 
histopathology scoring of panel i mice. a, Bars = geometric mean ± s.e.m. i, Bars = mean. 
*P< 0.05, **P< 0.01, ***P< 0.001; n.s., not significant.
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Extended Data Figure 10. In vitro growth curves of microcin M (mcmA) and microcin H47 
(mchB) EcN mutants in competition with commensal E. coli, S. Typhimurium, or AIEC
a–h, Strains were grown overnight in Nutrient Broth + 0.2 mM 2,2′-dipyridyl. Growth 
assays were performed in iron-limiting conditions (DMEM/F12 + 10% FBS) and timepoints 
at 0, 5, 8 and 11 hours post-inoculation were collected. a–c, CFU/mL of (a) commensal E. 
coli, (b) STm or (c) AIEC when grown alone or in competition with the indicated EcN 
strain. d, CFU/mL of complemented and uncomplemented EcN microcin immunity gene 
mutants when in competition with EcN wild-type. e, CFU/mL of wild-type STm or STm 
harboring pMchI or pMcmI when in competition with EcN wild-type. f-h, CFU/mL of (f) 
STm fepA, (g) STm iroN and (h) STm fepA iroN in competition with either wild-type EcN 
or EcN mcmA mchB. a–h, Symbols = geometric mean (three independent experiments) ± 
s.e.m. *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Microcins do not promote bacterial competition in the absence of intestinal 
inflammation
a,c,e,g, SPF streptomycin-treated (day -1) mice or b,d,f, germ-free mice were 
intragastrically inoculated with indicated E. coli strain(s). a–d, CFU/mg feces from (a,c) 
SPF or (c,d) germ-free mice on days 1–5 post-inoculation. e,f, Ratio (EcN over commensal) 
of (e) panels a,c or (f) panels b,d; bars = mean ± s.e.m. g, Cecal histopathology scores for 
panels a,c mice. a–d,g, Symbol = individual mouse; bars = geometric mean. h, gapA-
normalized mcmA (microcin M) and mchB (microcin H47) mRNA levels in iron-rich and 
iron-limited media. Bars = geometric mean (three independent experiments) ± s.e.m. 
*P<0.05, **P<0.01; n.s., not significant. Unpaired Student’s t test was utilized for statistical 
comparisons in panel h, Mann-Whitney-Wilcoxon for all other comparisons; P-values are 
presented in Supplementary Table 7.
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Figure 2. Microcins enable E. coli Nissle to limit the expansion of a commensal E. coli in the 
inflamed gut
a, Experimental design for b–d. b–d, (b) Ratio (EcN over commensal) or (c,d) CFU/mg 
sample at days 1–5 post-intragastric inoculation of indicated E. coli strain(s). b, Bars = mean 
± s.e.m. c,d, Symbol = individual mouse; bars = geometric mean; data represent two 
experiments. *P<0.05, **P<0.01; n.s., not significant. Statistics in black compare same 
timepoint; red compare different timepoints. Mann-Whitney-Wilcoxon was utilized for all 
statistical comparisons; P-values are presented in Supplementary Table 7.
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Figure 3. E. coli Nissle utilizes microcins to outcompete an enteric pathogen when the strains are 
co-administered
a, Experimental design for b,c. b,c, (b) CFU/mg feces or (c) competitive index (CI; EcN 
wild-type over mutant) at days 1–5 post-intragastric inoculation of indicated E. coli strains. 
d, Co-administration design for e-g. e–g, (e) Ratio (EcN over STm) or (f,g) CFU/mg feces at 
designated timepoints post-intragastric inoculation of indicated strain(s). c,e, Bars = mean ± 
s.e.m. b,f,g, symbol = mouse; bars = geometric mean; data represent 2 independent 
experiments. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001; n.s., not significant. Statistics 
in black compare same timepoint; red compares different timepoints. Mann-Whitney-
Wilcoxon was utilized for all statistical comparisons; P-values are presented in 
Supplementary Table 7.
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Figure 4. Microcins therapeutically reduce colonization of an enteric pathogen in the inflamed 
gut
a, Therapeutic design for b–d and Extended Data Fig. 9. b, Salmonella CFU/mg feces, days 
1 and 4–7 post-infection. For panel b mice, day 7: c, cecal mRNA levels; d, weight loss. b, 
symbol = mouse; bars = geometric mean; data represent 2 independent experiments. c,d, 
Bars = mean ± s.e.m. *P<0.05, **P<0.01, ***P<0.001; n.s., not significant. Statistics in 
black compare to STm (+mock); red compares to STm (+EcN wt). Mann-Whitney-
Wilcoxon was utilized for all statistical comparisons; P-values are presented in 
Supplementary Table 7.
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